Literature DB >> 3154643

The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction.

R C de Nooijer1, E E van der Wall, V M Cats, G van Herpen, A van der Laarse, J A Blokland, W Jaarsma, J W Arndt, A V Bruschke.   

Abstract

The acute effects on left ventricular function of nisoldipine were studied in six patients 56 +/- 12 hours (range 44 to 72 hours) after the onset of uncomplicated acute myocardial infarction. Nisoldipine was administered as a 4.5 micrograms/kg intravenous bolus over 3 minutes followed by an infusion of 0.2 microgram/kg during 60 minutes. Radionuclide angiography and two-dimensional echocardiography were performed before and during infusion with nisoldipine. The left ventricular ejection fraction increased significantly from 38% +/- 10% to 49% +/- 10% (P = 0.028) during nisoldipine infusion. Regional wall motion index was determined both by radionuclide and by two-dimensional echocardiography and showed a significant change during nisoldipine infusion from 1.9 +/- 0.3 to 1.5 +/- 0.3 (p = 0.028, radionuclide angiography) and from 0.7 +/- 0.2 to 0.3 +/- 0.2 (p = 0.043, two dimensional echocardiography). Heart rate increased significantly from 78 +/- 12 min-1 to 92 +/- 13 min-1 (p = 0.028), but mean double product did not change significantly during nisoldipine infusion. It is concluded that nisoldipine significantly improves global and regional left ventricular function in patients shortly after acute myocardial infarction. This beneficial effect may, however, be partially offset by an increase in heart rate. Since mean double product did not change, it is suggested that nisoldipine may improve coronary blood flow in patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3154643     DOI: 10.1007/bf00054208

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  37 in total

1.  Cardioprotective actions of nisoldipine in postreperfusion myocardial ischemia.

Authors:  R K Mentley; M E Brezinski; E Tse; A M Lefer
Journal:  Am Heart J       Date:  1988-05       Impact factor: 4.749

2.  Evaluation of the Penàz servo-plethysmo-manometer for the continuous, non-invasive measurement of finger blood pressure.

Authors:  G P Molhoek; K H Wesseling; J J Settels; E van Vollenhoven; H W Weeda; B de Wit; A C Arntzenius
Journal:  Basic Res Cardiol       Date:  1984 Sep-Oct       Impact factor: 17.165

3.  Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.

Authors:  C W Hamm; L H Opie
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

4.  Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.

Authors:  P A Sirnes; K Overskeid; T R Pedersen; J Bathen; A Drivenes; G S Frøland; J K Kjekshus; K Landmark; R Rokseth; K E Sirnes
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

5.  Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.

Authors:  D C Warltier; C M Meils; G J Gross; H L Brooks
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

6.  Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics.

Authors:  P W Serruys; H Suryapranata; J Planellas; W Wijns; G L Vanhaleweyk; A Soward; B E Jaski; P G Hugenholtz
Journal:  Am J Cardiol       Date:  1985-07-01       Impact factor: 2.778

7.  Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.

Authors:  G D Gordon; T A Mabin; S Isaacs; E A Lloyd; H G Eichler; L H Opie
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

8.  Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.

Authors: 
Journal:  Eur Heart J       Date:  1988-04       Impact factor: 29.983

9.  Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.

Authors: 
Journal:  Br Heart J       Date:  1986-11

10.  Coronary and systemic hemodynamic effects of intravenous nisoldipine.

Authors:  A L Soward; P J De Feyter; P G Hugenholtz; P W Serruys
Journal:  Am J Cardiol       Date:  1986-12-01       Impact factor: 2.778

View more
  1 in total

1.  Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction.

Authors:  E E van der Wall; V M Cats; J C Chin; E J Pauwels; A V Bruschke
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.